Kim J, Hwang HK, Lee WJ, Kang CM. Minimally invasive
vs open pancreatectomy for nonfunctioning pancreatic neuroendocrine tumors.
World J Gastrointest Oncol 2020;
12:1133-1145. [PMID:
33133382 PMCID:
PMC7579734 DOI:
10.4251/wjgo.v12.i10.1133]
[Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 06/21/2020] [Revised: 08/17/2020] [Accepted: 09/14/2020] [Indexed: 02/05/2023] Open
Abstract
BACKGROUND
The mainstay of treating nonfunctioning-pancreatic neuroendocrine tumors(NF-PNETs) is surgical resection. However, minimally invasive approaches to pancreatic resection for treating NF-PNETs are not widely accepted, and the long-term oncological outcomes of such approaches remain unknown.
AIM
To determine the short- and long-term outcomes of minimally invasive pancreatic resection conducted in patients with NF-PNETs.
METHODS
Prospective databases from Severance Hospital were searched for 110 patients who underwent curative resection for NF-PNETs between January 2003 and August 2018.
RESULTS
The proportion of minimally invasive surgery (MIS) procedures performed for NF-PNET increased to more than 75% after 2013. There was no significant difference in post-operative complications (P = 0.654), including pancreatic fistula (P = 0.890) and delayed gastric emptying (P = 0.652), between MIS and open approaches. No statistically significant difference was found in disease-free survival between the open approach group and the MIS group (median follow-up period, 28.1 mo; P = 0.428). In addition, the surgical approach (MIS vs open) was not found to be an independent prognostic factor in treating NF-PNET patients [Exp(β) = 1.062; P = 0.929].
CONCLUSION
Regardless of the type of surgery, a minimally invasive approach can be safe and feasible for select NF-PNET patients.
Collapse